Advertisement Inspire Pharmaceuticals names new board member - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Inspire Pharmaceuticals names new board member

Inspire Pharmaceuticals, a biopharmaceutical company, has appointed Alan Holmer to its board of directors.

Mr Holmer previously served for two years on Inspire’s board, resigning in February 2007 to accept an appointment in the US Treasury Department.

Mr Holmer has received an AB degree from Princeton University and a JD from Georgetown University.

Kenneth Lee, Jr, chairman of Inspire, said: “We are pleased to have Alan rejoin Inspire’s board of directors. Alan has broad knowledge of the pharmaceutical industry and global markets, which will be particularly valuable in the current challenging economic environment.

“Most importantly, we appreciate Alan’s understanding of Inspire’s business opportunities and his passion for providing patients with innovative therapeutic treatments.”